The economist thinks the Fed ought to pay more attention to financial markets when setting interest rates.The Fedread more
U.S. President Donald Trump's latest tariff increase — and Beijing's plans to counter them — are hitting U.S. companies in China, according to a joint survey this month by...China Economyread more
"We are also constantly watching whether the trade war will turn into a tech war," Ma said Tuesday, according to a CNBC translation of his Chinese remarks published by a locak...China Economyread more
Kohl's, J.C. Penney and Nordstrom release disappointing earnings news, putting a damper on their sector.Retailread more
Bezos's comments give a rare glimpse into his interest in the auto industry. Amazon recently invested in two self-driving start-ups.Technologyread more
While investing often seems like a contrarian game where going against the flow feels like the better bet, the reality is that investors who bought the most-favored stocks...Hedge Fundsread more
Talks between the world's two largest economies have stalled after each nation lobbied higher tariffs on the other's imports.Traderead more
"Pretty much the entire suite of apps that 'talk' over the internet could be vulnerable," said Tom Uren, a senior analyst at the Australian Strategic Policy Institute's...Cybersecurityread more
A Chinese official in Hong Kong is urging the quick passage of legal measures to allow fugitives to be transferred to the mainland.China Politicsread more
GAC Motor said its delaying its launch in the U.S. but had no timeline when it could launch there.Autosread more
The U.S. administration is considering limits to Chinese video surveillance firm Hikvision's ability to buy U.S. technology, the New York Times reported on Tuesday, deepening...World Politicsread more
Zimmer Biomet, a medical device maker based in Indiana, announced Tuesday it was initially pricing its secondary offering of 11.1 million common shares at $115.85.
Shares of the company dropped about 1.5 percent to about $116 a share.
The offering is being underwritten by Goldman Sachs and JPMorgan Chase and is expected to close June 16.
The company recently announced LDR Holding for $1 billion, paying a 64 percent premium on the company's closing stock price at the time of the deal. The acquisition of LDR is expected to close in the third quarter. Since January, Zimmer Biomet's stock is up more than 13 percent.
Zimmer Biomet makes reconstructive surgical devices such as hip replacement products.
ZBH in 2016